PDC and anemia: Nonetheless, given that there is preliminary evidence that EPO treatment may have clinical benefit in treatment of mild to moderate AD,88, 89 empirically guided approaches involving boosting EPO levels/oxygen supply to the brain via use of the currently available PHD inhibitors developed for treatment of anemia by the promotion of erythropoiesis may be of interest.